In addition, Lin28 is also overexpressed in hepatocellular carcinoma, and regulating Lin28B enhance the anti-tumor activity of GPC3 CAR-T cells, enabling GPC3 CAR-T cells to better treat hepatocellular carcinoma (84). This evidence concerns the gene LIN28B and hepatocellular carcinoma.